Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,878 | -9,491 | 440,302 | 422,775 | 625,154 |
| Depreciation Amortization | 6,118 | 3,062 | 27,613 | 22,488 | 15,903 |
| Accounts receivable | 95,116 | 86,243 | 61,040 | 112,980 | -94,947 |
| Other Working Capital | -58,262 | -25,012 | -887,705 | -814,003 | -979,930 |
| Other Operating Activity | -85,324 | -87,225 | 114,115 | 50,600 | 120,856 |
| Operating Cash Flow | $-105,230 | $-32,423 | $-244,635 | $-205,160 | $-312,964 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -31,356 | -66,841 | -91,532 | -94,611 | 39,901 |
| PPE Investments | -1,858 | -1,270 | -5,560 | -3,484 | -2,122 |
| Purchase Sale Intangibles | N/A | N/A | -828 | -655 | N/A |
| Other Investing Activity | 39,750 | 39,750 | 18,825 | -655 | 0 |
| Investing Cash Flow | $6,536 | $-28,361 | $-78,267 | $-98,750 | $37,779 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 46,411 | 46,411 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 42,606 | 42,606 | N/A |
| Debt Repayment | -1,104 | -578 | -10,071 | -3,797 | -2,813 |
| Common Stock Issued | -6,431 | -8,158 | -4,798 | -4,468 | -5,288 |
| Financing Cash Flow | $38,876 | $37,675 | $27,737 | $34,341 | $-8,101 |
| Exchange Rate Effect | -194 | -18 | 5,925 | 7,634 | 6,976 |
| Beginning Cash Position | 256,052 | 256,052 | 545,292 | 545,292 | 545,292 |
| End Cash Position | 196,040 | 232,925 | 256,052 | 283,357 | 268,982 |
| Net Cash Flow | $-60,012 | $-23,127 | $-289,240 | $-261,935 | $-276,310 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,230 | -32,423 | -244,635 | -205,160 | -312,964 |
| Capital Expenditure | -1,858 | -1,270 | -5,560 | -3,484 | -2,122 |
| Free Cash Flow | -107,088 | -33,693 | -250,195 | -208,644 | -315,086 |